Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dimitri P Mikhailidis

Showing results (231-240 of 675) with videos related to

Pageof 68
Sort By:
Expert Opinion on Investigational Drugs|September 15, 2015
An evaluation of RVX-208 for the treatment of atherosclerosisDragana Nikolic, Manfredi Rizzo, Dimitri P Mikhailidis, et al.
Expert Opinion on Drug Safety|August 22, 2018
Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2Antonis A Manolis, Theodora A Manolis, Dimitri P Mikhailidis, et al.
Clinical Rheumatology|December 21, 2006
Oral and ocular/orbital manifestations of temporal arteritis: a disease with deceptive clinical symptoms and devastating consequencesKosmas I Paraskevas, Dimitrios T Boumpas, George E Vrentzos, et al.
Angiology|March 14, 2007
Thromboangiitis obliterans (Buerger's disease): searching for a therapeutic strategyKosmas I Paraskevas, Christos D Liapis, Despina D Briana, et al.
Current Hypertension Reports|May 24, 2007
Analysis of antihypertensive effects of statinsHaralampos J Milionis, Evagelos N Liberopoulos, Moses S Elisaf, et al.
Atherosclerosis|December 3, 2014
ETC-1002: a future option for lipid disorders?Dragana Nikolic, Dimitri P Mikhailidis, Michael H Davidson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2009
Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesisPanagiotis Anagnostis, Vasilios G Athyros, Konstantinos Tziomalos, et al.
Expert Opinion on Therapeutic Targets|February 25, 2009
HSP 70 and atherosclerosis--protector or activator?Agata Bielecka-Dabrowa, Marcin Barylski, Dimitri P Mikhailidis, et al.
Current Medical Research and Opinion|February 6, 2010
Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?Vasilios G Athyros, Konstantinos Tziomalos, Matilda Florentin, et al.
Current Vascular Pharmacology|January 26, 2012
Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an updateKosmas I Paraskevas, Frank J Veith, Christos D Liapis, et al.
Pageof 68

Showing results (231-240 of 675) with videos related to

Sort By:
Pageof 68
Expert Opinion on Investigational Drugs|September 15, 2015
An evaluation of RVX-208 for the treatment of atherosclerosisDragana Nikolic, Manfredi Rizzo, Dimitri P Mikhailidis, et al.
Expert Opinion on Drug Safety|August 22, 2018
Cardiovascular safety of oncologic agents: a double-edged sword even in the era of targeted therapies - Part 2Antonis A Manolis, Theodora A Manolis, Dimitri P Mikhailidis, et al.
Clinical Rheumatology|December 21, 2006
Oral and ocular/orbital manifestations of temporal arteritis: a disease with deceptive clinical symptoms and devastating consequencesKosmas I Paraskevas, Dimitrios T Boumpas, George E Vrentzos, et al.
Angiology|March 14, 2007
Thromboangiitis obliterans (Buerger's disease): searching for a therapeutic strategyKosmas I Paraskevas, Christos D Liapis, Despina D Briana, et al.
Current Hypertension Reports|May 24, 2007
Analysis of antihypertensive effects of statinsHaralampos J Milionis, Evagelos N Liberopoulos, Moses S Elisaf, et al.
Atherosclerosis|December 3, 2014
ETC-1002: a future option for lipid disorders?Dragana Nikolic, Dimitri P Mikhailidis, Michael H Davidson, et al.
The Journal of Clinical Endocrinology and Metabolism|May 28, 2009
Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesisPanagiotis Anagnostis, Vasilios G Athyros, Konstantinos Tziomalos, et al.
Expert Opinion on Therapeutic Targets|February 25, 2009
HSP 70 and atherosclerosis--protector or activator?Agata Bielecka-Dabrowa, Marcin Barylski, Dimitri P Mikhailidis, et al.
Current Medical Research and Opinion|February 6, 2010
Statin loading in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a new pleiotropic effect?Vasilios G Athyros, Konstantinos Tziomalos, Matilda Florentin, et al.
Current Vascular Pharmacology|January 26, 2012
Perioperative/periprocedural effects of statin treatment for patients undergoing vascular surgery or endovascular procedures: an updateKosmas I Paraskevas, Frank J Veith, Christos D Liapis, et al.
Pageof 68